. Author manuscript; available in PMC: 2013 Dec 20.

Published in final edited form as: Int J Gynecol Cancer. 2010 Apr;20(3):10.1111/IGC.0b013e3181d24ce0. doi: 10.1111/IGC.0b013e3181d24ce0

TABLE 4.

Intercorrelations among the predictors, outcome, and control variables

Variable	Sexual Morbidity	CES-D	PCL-C	IES	ITS	SF-12 MCS	SF-12 PCS
Psychological adjustment
CES-D	0.34^*
PCL-C	0.30^*
IES-R	0.10
ITS	0.25^*
QoL
SF-12 MCS	−0.24^*
SF-12 PCS	−0.34^*
Sociodemographics
Age	0.31^*	−0.22^*	0.30^*	−0.18^†	−0.26^*	−0.08	−0.28^*
Race	0.11	0.00	−0.04	0.09	0.08	0.21^*	0.10
Education	−0.11	0.30^*	0.07	−0.24^*	0.00	−0.11	0.07
Family income	−0.08	0.13	−0.05	0.05	−0.02	−0.03	−0.08
Employment status	−0.32^*	0.33^*	0.05	−0.17^†	−0.04	−0.08	0.03
Health status
Performance status (KPS)	−0.36^*	0.65^*	0.22^*	−0.46^*	−0.16^†	−0.27^*	−0.33^*
Symptoms/signs (SWOG)	0.20^*	−0.28^*	−0.13	0.24^*	0.08	0.20^*	0.16^†
Fatigue (FSI TDI)	0.44^*	−0.55^*	−0.47^*	0.67^*	0.21^*	0.46^*	0.43^*
Disease and treatment characteristics
Stage	0.09	−0.13	0.08	−0.03	0.09	−0.04	0.01
Time since diagnosis	−0.01	0.03	0.13	−0.14	−0.11	−0.02	−0.08
Hysterectomy (yes, 1)	0.07	0.07	0.08	0.03	0.01	0.05	0.02
Chemotherapy (yes, 1)	−0.02	−0.02	0.10	−0.09	0.06	0.01	−0.07
Radiation (yes, 1)	0.07	−0.11^†	−0.02	−0.02	0.01	−0.01	0.00
Recurred (yes, 1)	0.20^*	−0.18^†	0.00	0.03	−0.04	−0.02	0.02

P < 0.01.

^†

P < 0.05.

SWOG, Southwest Oncology Collaborative Group.